PortfoliosLab logoPortfoliosLab logo
IOVA vs. CORT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IOVA vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IOVA achieves a 38.83% return, which is significantly lower than CORT's 108.76% return. Over the past 10 years, IOVA has underperformed CORT with an annualized return of -7.92%, while CORT has yielded a comparatively higher 28.72% annualized return.


IOVA

1D
-7.56%
1M
-1.56%
YTD
38.83%
6M
71.49%
1Y
108.24%
3Y*
-24.48%
5Y*
-26.71%
10Y*
-7.92%

CORT

1D
2.04%
1M
40.79%
YTD
108.76%
6M
-13.17%
1Y
4.52%
3Y*
46.18%
5Y*
27.68%
10Y*
28.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IOVA vs. CORT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IOVA
Iovance Biotherapeutics, Inc.
38.83%-63.11%-8.98%27.23%-66.53%-58.86%67.63%212.77%10.62%15.11%
CORT
Corcept Therapeutics Incorporated
108.76%-30.94%55.14%59.92%2.58%-24.31%116.20%-9.43%-26.02%148.76%

Correlation

The correlation between IOVA and CORT is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Oct 18, 2010

0.22

Fundamentals

Market Cap

IOVA:

$1.59B

CORT:

$7.59B

EPS

IOVA:

-$0.93

CORT:

$0.41

PS Ratio

IOVA:

5.06

CORT:

10.96

PB Ratio

IOVA:

2.20

CORT:

11.89

Total Revenue (TTM)

IOVA:

$285.61M

CORT:

$769.10M

Gross Profit (TTM)

IOVA:

$327.04M

CORT:

$755.64M

EBITDA (TTM)

IOVA:

-$325.45M

CORT:

$3.66M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IOVA vs. CORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOVA
IOVA Risk / Return Rank: 7272
Overall Rank
IOVA Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
IOVA Sortino Ratio Rank: 7777
Sortino Ratio Rank
IOVA Omega Ratio Rank: 7272
Omega Ratio Rank
IOVA Calmar Ratio Rank: 7373
Calmar Ratio Rank
IOVA Martin Ratio Rank: 6666
Martin Ratio Rank

CORT
CORT Risk / Return Rank: 4545
Overall Rank
CORT Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
CORT Sortino Ratio Rank: 4545
Sortino Ratio Rank
CORT Omega Ratio Rank: 5454
Omega Ratio Rank
CORT Calmar Ratio Rank: 4242
Calmar Ratio Rank
CORT Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IOVA vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IOVACORTDifference
Sharpe ratioReturn per unit of total volatility

+1.01

Sortino ratioReturn per unit of downside risk

+1.51

Omega ratioGain probability vs. loss probability

1.25

1.14

+0.11

Calmar ratioReturn relative to maximum drawdown

2.00

0.07

+1.93

Martin ratioReturn relative to average drawdown

3.14

0.13

+3.01

IOVA vs. CORT - Sharpe Ratio Comparison

The current IOVA Sharpe Ratio is 1.07, which is higher than the CORT Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of IOVA and CORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IOVACORTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.07

0.06

+1.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

0.37

-0.67

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.10

0.43

-0.53

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

0.11

-0.24

Drawdowns

IOVA vs. CORT - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than CORT's maximum drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for IOVA and CORT.


Loading charts...

Drawdown Indicators


IOVACORTDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-94.28%

-5.09%

Max Drawdown (1Y)

Largest decline over 1 year

-54.41%

-64.40%

+9.99%

Max Drawdown (3Y)

Largest decline over 3 years

-90.50%

-71.85%

-18.65%

Max Drawdown (5Y)

Largest decline over 5 years

-93.99%

-71.85%

-22.14%

Max Drawdown (10Y)

Largest decline over 10 years

-96.84%

-71.85%

-24.99%

Current Drawdown

Current decline from peak

-97.62%

-36.39%

-61.23%

Average Drawdown

Average peak-to-trough decline

-84.16%

-53.45%

-30.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.64%

35.28%

-0.64%

Volatility

IOVA vs. CORT - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 24.33% compared to Corcept Therapeutics Incorporated (CORT) at 16.23%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IOVACORTDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.33%

16.23%

+8.10%

Volatility (6M)

Calculated over the trailing 6-month period

62.96%

85.05%

-22.09%

Volatility (1Y)

Calculated over the trailing 1-year period

101.64%

76.53%

+25.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.79%

74.50%

+15.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.28%

67.20%

+14.08%

Dividends

IOVA vs. CORT - Dividend Comparison

Neither IOVA nor CORT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IOVA vs. CORT - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
71.43M
164.90M
(IOVA) Total Revenue
(CORT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IOVA and CORT have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IOVA has higher volatility (24.33%) compared to CORT (16.23%). In terms of maximum drawdown, IOVA dropped -99.37% vs CORT's -94.28%.

IOVA currently has the higher Sharpe Ratio (1.07 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IOVA and CORT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer